Felicity Huffman Joins with the Entertainment Industry Foundation and AstraZeneca in National Public Education Campaign Directed Toward Breast Cancer Survivors
Effort aimed at increasing awareness about the risk of breast cancer recurrence and how to reduce it

Los Angeles, Calif. (December 2007) &madash; Award-winning actress Felicity Huffman has been named an ambassador for a new public service campaign targeted toward breast cancer survivors, which will begin airing this fall.

The public service campaign, "If You Were My Sister," was created in partnership between the Women's Cancer Programs of the Entertainment Industry Foundation (EIF) and AstraZeneca to raise awareness among breast cancer survivors about reducing the risk of recurrence.

"Unfortunately, breast cancer can return, and many women lack vital information about how to reduce their risk of recurrence," Huffman states. "That's why I am involved in this important campaign on behalf of the Entertainment Industry Foundation. We have all had family and friends who are touched by this disease, and I want to help educate women about what they need to know, and can do, to reduce their risk."

Today, more than two million women in the U.S. are breast cancer survivors. Yet many of them lack crucial information about treatment choices after surgery, where to find help and support groups, and why they must be diligent about following the treatment prescribed by their doctors.

"We want all women who have survived breast cancer to know there are good reasons to be optimistic," said Lisa Schoenberg, vice president of specialty care at AstraZeneca. "AstraZeneca is delighted to have this opportunity to partner with Felicity Huffman and EIF on this important breast cancer awareness initiative. Together, we will be able to reach those impacted by this disease with a clear message: there is information available and steps breast cancer survivors can take to reduce their risk of recurrence."

Huffman, an Emmy Award winner and Academy Award nominee, will appear in both a broadcast and print public service announcement (PSA). The broadcast PSA was directed by award-winning Director Patricia Cardoso. The print PSA will reflect the feeling and sentiments of the broader "If You Were My Sister" campaign created by AstraZeneca.

Click here to view the Print PSA.

Click here to view the video PSA.

The overarching program is also designed to enhance awareness of the risk of breast cancer recurrence and how to reduce that risk among survivors. The major elements of the campaign are the PSA, both broadcast and print, an interactive Web site called getbcfacts.com, and an educational information kit-all featuring real women who are breast cancer survivors. The campaign encourages the public to learn and share critical information about the risk of breast cancer recurrence.

"For more than 15 years, the Entertainment Industry Foundation has been deeply involved in raising funds for breast cancer research and advocacy and in encouraging women to get screened," said Lisa Paulsen, president and CEO of EIF. "We're thrilled to be part of a campaign that focuses on getting the word out to the growing survivor community about the risk of recurrence, and most importantly, about how to reduce it. We're extremely grateful to Felicity Huffman for volunteering her time to this very worthwhile cause."

To learn more about breast cancer recurrence, call 1-877-OUR-SISTERS or visit www.getbcfacts.com.

ABOUT BREAST CANCER Breast cancer is the most frequently diagnosed cancer in women and is the second leading cause of cancer deaths in women, exceeded only by lung cancer. It is estimated that 40,460 women will die of the disease in 2007.¹ Mammography screening, which is recommended annually for women 40 years of age and older, frequently detects early signs of breast cancer and, thus, improves survival chances. After increasing for over two decades, female breast cancer incidence rates leveled off from 2001 to 2003.¹ Mortality rates in women have steadily declined since 1990, decreasing by 3.3 percent per year in women younger than 50 and 2.0 percent per year in those 50 years and older.¹

ABOUT ASTRAZENECA
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. AstraZeneca has been named one of the "100 Best Companies for Working Mothers" by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine's 2007 list of "100 Best Companies to Work For." In 2006, for the fifth consecutive year, Science magazine named AstraZeneca a "Top Employer" on its ranking of the world's most respected biopharmaceutical employers.

For more information about AstraZeneca, please visit: www.astrazeneca-us.com

ABOUT THE ENTERTAINMENT INDUSTRY FOUNDATION
The Entertainment Industry Foundation (EIF), as a leading charitable organization of the entertainment industry, has distributed hundreds of millions of dollars to support charitable initiatives addressing critical health, education and social issues.

Through its Women's Cancer Programs, the Entertainment Industry Foundation is committed to saving lives by raising awareness about the importance of early detection of breast and reproductive cancers, providing funds to advance treatment research, early detection methods, and supporting community programs that assist the millions of women and their families at risk of or affected by cancer. EIF has a remarkable track record in raising awareness and funds in the fight against cancer. EIF's funding strategy is results-driven, bringing together some of the very best scientists and institutions in the country to collaborate in groundbreaking research projects to fast-track better prevention methods and improved therapies for treatment of breast and other women's cancers.

¹ American Cancer Society, "Cancer Facts & Figures," 2007

Contact:
Maurine Slutzky
Entertainment Industry Foundation
213.240.3923
mslutzky@eifoundaton.org

Katie Neff
Astra Zeneca
302-885-9960
katie.neff@astrazeneca.com